Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Overcoming Erlotinib Resistance in <i>EGFR</i> Mutation–Positive Non–Small Cell Lung Cancer Cells by Targeting Survivin

PaperCitations, authors & open-access status

Overcoming Erlotinib Resistance in <i>EGFR</i> Mutation–Positive Non–Small Cell Lung Cancer Cells by Targeting Survivin is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 68 citations, 2011 year and closed oa status.

68
Citations
2011
Year
closed
OA Status

Related on ScholarIQ

Kunio Okamoto
Author
PI3K/AKT/mTOR signaling in cancer
Topic
PI3K/AKT/mTOR signaling in cancer
Topic
Lung Cancer Treatments and Mutations
Topic
Cell death mechanisms and regulation
Topic
470M+ articles · free account